Evidence map›Paper›PMID 32714871›Full record

ArticleFrontiers in oncology2020

Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic.

Helano C Freitas, Giovana Tardin Torrezan, Isabela Werneck da Cunha, Mariana Petaccia Macedo, Vanessa Karen de Sá, Marcelo Corassa, Elisa Napolitano E Ferreira, Augusto Obuti Saito, Graziela Zibetti Dal Molin, Vladmir C Cordeiro de Lima and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Prevalence ofJournal of thoracic disease · 2025
    Article
  2. Review
  3. Observational
  4. Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2023
    Article
  5. Article
  6. Article
  7. Frequency ofJCO global oncology · 2021
    Article
  8. Testing forOncoTargets and therapy · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Helano C FreitasMedical Oncology Department, A.C. Camargo Cancer Center, São Paulo, Brazil.
Giovana Tardin TorrezanGenomics and Molecular Biology Group, International Research Center, A.C. Camargo Cancer Center, São Paulo, Brazil.
Isabela Werneck da CunhaAnatomic Pathology Department, A.C. Camargo Cancer Center, São Paulo, Brazil.
Mariana Petaccia MacedoAnatomic Pathology Department, A.C. Camargo Cancer Center, São Paulo, Brazil.
Vanessa Karen de SáMedical Oncology Department, A.C. Camargo Cancer Center, São Paulo, Brazil.
Marcelo CorassaMedical Oncology Department, A.C. Camargo Cancer Center, São Paulo, Brazil.
Elisa Napolitano E FerreiraGenomics and Molecular Biology Group, International Research Center, A.C. Camargo Cancer Center, São Paulo, Brazil.
Augusto Obuti SaitoMedical Oncology Department, A.C. Camargo Cancer Center, São Paulo, Brazil.
Graziela Zibetti Dal MolinMedical Oncology Department, A.C. Camargo Cancer Center, São Paulo, Brazil.
Vladmir C Cordeiro de LimaMedical Oncology Department, A.C. Camargo Cancer Center, São Paulo, Brazil.
Dirce Maria CarraroGenomics and Molecular Biology Group, International Research Center, A.C. Camargo Cancer Center, São Paulo, Brazil.
AC Camargo Hospital · BRGenomic (Brazil) · BRBeneficência Portuguesa de São Paulo · BRD’Or Institute for Research and Education · BRFleury S.A. (Brazil) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

driver mutationsEGFRlung adenocarcinomamolecular testingtargeted therapies

Identifiers

PMID32714871
PMCPMC7343968
OpenAlexW3038267939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.